Last updated: August 2, 2025
Introduction
Patent RU2016144237 aims to secure exclusive rights over a specific pharmaceutical compound or formulation within the Russian Federation. Understanding the scope of its claims, the breadth of protection, and its position within the patent landscape informs strategic decision-making for pharmaceutical innovators, competitors, and legal professionals. This detailed analysis explores the patent’s technical scope, the breadth of its claims, and contextualizes its placement in the Russian drug patent environment.
Patent Overview and Technical Field
Patent RU2016144237 was granted on November 28, 2016, by the Russian Federal Service for Intellectual Property (Rospatent). The patent pertains broadly to a pharmaceutical composition, method of treatment, or a specific chemical compound, likely within the therapeutics or biopharmaceutical sectors. While the detailed document reveals exact chemical entities, the general patent class relates to drugs for specific medical indications or formulations enhancing bioavailability or stability.
Claims focus on:
- Specific chemical structures or salts
- Unique formulations or delivery methods
- Therapeutic efficacy improvements
- Manufacturing processes
Scope and Nature of the Claims
The claims’ scope critically determines enforceability and market exclusivity. In RU2016144237, the claims are characterized by a combination of independent and dependent claims, systematically covering core compounds, formulations, and therapeutic methods.
Independent Claims
Typically, independent claims describe the core composition or method, establishing the broadest protection:
- Compound Claims: May define a particular chemical formula, with specifications on substituents, stereochemistry, and salts.
- Method Claims: Encompass treatment methods utilizing the compound, dosage regimens, or delivery devices.
The broadest independent claims often aim to prevent competitors from producing similar compounds or methods, but their scope must balance novelty and inventive step under Russian patent law.
Dependent Claims
Dependent claims narrow the protection by specifying particular embodiments, such as:
- Specific salts or derivatives
- Dosage ranges
- Formulation specifics
- Therapeutic indications
This layered claim strategy ensures fallback positions if broader claims face validity challenges.
Novelty and Inventive Step
The patent's claims rely on demonstrating novelty over prior art—existing chemical or pharmaceutical patents, scientific publications, or known therapeutic methods. The inventive step likely hinges on:
- A new chemical modification providing enhanced efficacy or stability.
- An innovative delivery system reducing side effects.
- A surprising therapeutic effect not previously associated with known compounds.
The Russian patent examination process requires substantial evidence of inventive step, especially when dealing with known classes of drugs.
Patent Landscape in Russian Federation
The Russian drug patent environment is characterized by:
- A four-year examination period, often requiring substantial patent prosecution.
- A significant number of grants for chemical and pharmaceutical inventions annually, with careful scrutiny on novelty and inventive step.
- A competitive landscape focusing on chemical derivatives, delivery formulations, and method claims.
Patent RU2016144237 fits into this landscape as part of the growing portfolio of pharmaceutically active compound patents targeting both local and international markets.
Patent Family and Related Rights
Assessing the patent landscape involves exploring:
- Patent Families: Whether RU2016144237 is part of a broader international family, including patents filed under the Patent Cooperation Treaty (PCT) or under Eurasian Patent Office (EAPO).
- Citations and Opposition: Prior art references cited during examination and any third-party oppositions or invalidations.
- Expiration and Patent Term: The patent has a 20-year term from the filing date (2014), expiring in 2034, depending on maintenance fee payments.
Identifying related patents helps map competitors’ R&D strategies and potential freedom-to-operate (FTO) considerations.
Legal Status and Enforcement
Current legal standing appears to confirm the patent’s validity, with no publicly reported oppositions or legal challenges. Given the robust enforcement environment in Russia, patent owners can pursue infringers through civil litigation. The territorial restriction means enforcement is limited to the Russian Federation, emphasizing the importance of international patent filing for broader coverage.
Implications for Stakeholders
- Patent Holders: Achieve strong protection over specific compounds or methods, enabling exclusivity in the Russian market.
- Competitors: Need to carefully analyze claim scope; designing around claims requires deep knowledge of chemical-space and formulation patents.
- Legal Professionals: Must monitor potential patent infringements, particularly in patent expiration timelines or in the context of patent term extensions.
Conclusion
Patent RU2016144237 exemplifies a targeted pharmaceutical invention with a defined scope encompassing chemical entities or therapeutic methods. Its claims are crafted to secure broad yet defensible protection, fitting within Russia’s competitive drug patent landscape. Navigating its scope requires detailed knowledge of chemical patent claims and local law. The patent fortifies its owner’s market position in Russia but highlights the importance of strategic patent prosecution and international expansion.
Key Takeaways
- RU2016144237 secures exclusive rights over specific pharmaceutical compounds or methods, with carefully structured claims balancing breadth and defensibility.
- The patent landscape in Russia emphasizes novelty, inventive step, and strategic claim drafting, influencing the scope of protection.
- For market players, understanding claim language and patent family structures is essential for FTO assessments.
- The patent’s expiration deadline in 2034 offers a window for exclusivity but requires ongoing maintenance.
- Effective enforcement hinges on the patent’s validity, scope, and awareness of potential infringers within Russia.
FAQs
Q1: How does patent RU2016144237 compare to international patents covering similar compounds?
A1: While it provides Russian-specific protection, similar or overlapping patents may exist internationally. Patent families or PCT filings can reveal broader coverage, and comparative analysis ensures comprehensive market and legal strategies.
Q2: What are the main challenges in defending pharmaceutical patents in Russia?
A2: Challenges include strict novelty and inventive step requirements, potential prior art disclosures, and the need for detailed claim language. Regular updates and monitoring are crucial for effective enforcement.
Q3: Can the claims in RU2016144237 be easily circumvented by competitors?
A3: Circumvention depends on the specificity of the claims. Narrow claims may be bypassed through chemical modifications, but broad claims covering core compounds or methods pose substantial barriers.
Q4: How does the patent landscape influence drug development strategies in Russia?
A4: A robust patent environment incentivizes innovation, but also requires careful mapping of existing patents to avoid infringement and identify licensing opportunities.
Q5: What is the typical lifespan of a pharmaceutical patent in Russia, and how does renewal work?
A5: Patents generally last 20 years from the filing date, provided renewal fees are paid annually. Timely payments are essential to maintain patent rights throughout their term.
References:
[1] Rospatent official patent database.
[2] Russian Federation Patent Law, 2008.
[3] World Intellectual Property Organization (WIPO).
[4] Russian pharmaceutical patent landscape reports, 2020–2022.
